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Most thyroid carcinomas originating from follicular cells
are diﬀerentiated carcinomas (DTC) that generally have an
indolent character and show a favorable prognosis if treated
appropriately. However, cases with certain clinicopatholog-
ical characteristics are progressive and life threatening. In
this special issue, scientiﬁc papers and reviews regarding
the prognosis and prognostic factors of thyroid carcinoma
patients were collated.
The ﬁrst paper is a review of prognostic factors of
DTC based on data from the Kuma Hospital, a hospital
specializing in thyroid care. Prominent prognostic factors
of DTC are indicated here in an orthodox fashion. The
second one demonstrated the diﬀerence in preoperative
thyrotropin serum concentrations according to the patho-
logical diagnosis: benign nodule, papillary microcarcinoma,
and clinical papillary carcinoma. It is well known that
clinical node metastasis detected on preoperative imaging
studies aﬀects the prognosis of papillary carcinoma patients,
as indicated in the ﬁrst paper. In the third paper, the
prognosis of patients showing clinical lateral node metastasis
on the side contralateral but not ipsilateral to the primary
lesions was investigated. Such cases generally show indolent
behavior. For surgery of papillary carcinoma, it remains
debatable whether central node dissection is important. The
fourth paper indicates frequent metastasis to the central
compartmentaswellasriskfactorsofcentralnodemetastasis
and concludes that total central node dissection is preferable
for papillary carcinoma.
Most prominent prognostic factors of papillary carci-
noma can be evaluated based on pre- and intraoperative
ﬁndings. However, pathological examination is also impor-
tant because there are some aggressive variants such as the
tall cell variant of papillary carcinoma. Furthermore, small
foci of anaplastic carcinoma or squamous cell carcinoma
may be detected, which signiﬁcantly predict a dire prognosis.
However, the ﬁfth paper demonstrated a comparatively
favorable prognosis of papillary thyroid carcinoma patients
with squamous cell carcinoma compartments if they can
successfully undergo locally curative surgery. Papillary carci-
noma shows locoregional recurrence much more frequently
than distant recurrence, and the organ in which papillary
carcinoma is most likely to recur is the regional lymph node.
However, papillary carcinoma recurrence can lead to various
other locoregional lesions. The sixth paper investigated the
clinical signiﬁcance of subcutaneous or intrastrap muscular
recurrence and showed that it is not fatal but is a predictor of
distant recurrence and that careful follow-up is required for
such patients.
The three papers from the seventh to ninth focused
on up-to-date topics. The seventh one demonstrated that
recombinant human thyrotropin-aided radioiodine therapy
is beneﬁcial for patients with metastatic DTC. The authors
showedthatthisstrategyyieldedatherapeuticbeneﬁtin39%
of patients who otherwise could not be eﬃciently treated
with 131I therapy. The eighth paper reviewed the role of
18FDG-PET for the diagnosis, prognosis, and management
of thyroid carcinoma. The ninth paper is also a review
of the RET rearrangement in Chernobyl-related thyroid
carcinoma. This theme is quite timely because of the Tohoku
disaster in Japan in March 2011.2 Journal of Thyroid Research
As indicated above, this special issue includes papers
investigating the prognosis of DTC patients from various
standpoints. I hope that this special issue signiﬁcantly con-
tributes to the advancement of thyroid carcinoma therapy.
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